POXEL SA (POXEL.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:POXEL • FR0012432516

0.292 EUR
-0.01 (-4.73%)
Last: Feb 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

1

Overall POXEL gets a fundamental rating of 1 out of 10. We evaluated POXEL against 81 industry peers in the Biotechnology industry. POXEL has a bad profitability rating. Also its financial health evaluation is rather negative. POXEL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year POXEL has reported negative net income.
  • POXEL had a positive operating cash flow in the past year.
  • In the past 5 years POXEL always reported negative net income.
  • POXEL had a negative operating cash flow in each of the past 5 years.
POXEL.PA Yearly Net Income VS EBIT VS OCF VS FCFPOXEL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • POXEL's Return On Assets of -272.29% is on the low side compared to the rest of the industry. POXEL is outperformed by 92.59% of its industry peers.
Industry RankSector Rank
ROA -272.29%
ROE N/A
ROIC N/A
ROA(3y)-313.52%
ROA(5y)-206.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
POXEL.PA Yearly ROA, ROE, ROICPOXEL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600

1.3 Margins

  • POXEL's Gross Margin of 52.02% is in line compared to the rest of the industry. POXEL outperforms 48.15% of its industry peers.
  • POXEL's Gross Margin has declined in the last couple of years.
  • POXEL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.62%
GM growth 5YN/A
POXEL.PA Yearly Profit, Operating, Gross MarginsPOXEL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • POXEL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • POXEL has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for POXEL has been increased compared to 5 years ago.
  • POXEL has a better debt/assets ratio than last year.
POXEL.PA Yearly Shares OutstandingPOXEL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
POXEL.PA Yearly Total Debt VS Total AssetsPOXEL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -31.52, we must say that POXEL is in the distress zone and has some risk of bankruptcy.
  • POXEL has a worse Altman-Z score (-31.52) than 81.48% of its industry peers.
  • The Debt to FCF ratio of POXEL is 74.74, which is on the high side as it means it would take POXEL, 74.74 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of POXEL (74.74) is better than 76.54% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 74.74
Altman-Z -31.52
ROIC/WACCN/A
WACC11.24%
POXEL.PA Yearly LT Debt VS Equity VS FCFPOXEL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

  • POXEL has a Current Ratio of 0.26. This is a bad value and indicates that POXEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of POXEL (0.26) is worse than 91.36% of its industry peers.
  • POXEL has a Quick Ratio of 0.26. This is a bad value and indicates that POXEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • POXEL's Quick ratio of 0.26 is on the low side compared to the rest of the industry. POXEL is outperformed by 91.36% of its industry peers.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.26
POXEL.PA Yearly Current Assets VS Current LiabilitesPOXEL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • POXEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.29%, which is quite impressive.
  • POXEL shows a strong growth in Revenue. In the last year, the Revenue has grown by 249.95%.
  • The Revenue for POXEL have been decreasing by -24.22% on average. This is quite bad
EPS 1Y (TTM)38.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.15%
Revenue 1Y (TTM)249.95%
Revenue growth 3Y-20.88%
Revenue growth 5Y-24.22%
Sales Q2Q%87.87%

3.2 Future

  • POXEL is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -21.44% yearly.
  • Based on estimates for the next years, POXEL will show a very negative growth in Revenue. The Revenue will decrease by -18.07% on average per year.
EPS Next Y-10.48%
EPS Next 2Y-21.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-79.58%
Revenue Next 2Y-18.07%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
POXEL.PA Yearly Revenue VS EstimatesPOXEL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
POXEL.PA Yearly EPS VS EstimatesPOXEL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • POXEL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year POXEL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
POXEL.PA Price Earnings VS Forward Price EarningsPOXEL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • 88.89% of the companies in the same industry are more expensive than POXEL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.24
EV/EBITDA N/A
POXEL.PA Per share dataPOXEL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

  • A cheap valuation may be justified as POXEL's earnings are expected to decrease with -21.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.44%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for POXEL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

POXEL SA

EPA:POXEL (2/9/2026, 7:00:00 PM)

0.292

-0.01 (-4.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)04-20
Inst Owners4.99%
Inst Owner ChangeN/A
Ins Owners3.45%
Ins Owner ChangeN/A
Market Cap15.70M
Revenue(TTM)7.66M
Net Income(TTM)-13.62M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.05
P/FCF 19.24
P/OCF 19.24
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-1.74
Fwd EYN/A
FCF(TTM)0.02
FCFY5.2%
OCF(TTM)0.02
OCFY5.2%
SpS0.14
BVpS-1.14
TBVpS-1.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -272.29%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.02%
FCFM 10.66%
ROA(3y)-313.52%
ROA(5y)-206.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.62%
GM growth 5YN/A
F-Score5
Asset Turnover1.53
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 74.74
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.26
Altman-Z -31.52
F-Score5
WACC11.24%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.15%
EPS Next Y-10.48%
EPS Next 2Y-21.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)249.95%
Revenue growth 3Y-20.88%
Revenue growth 5Y-24.22%
Sales Q2Q%87.87%
Revenue Next Year-79.58%
Revenue Next 2Y-18.07%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y80.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-223.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.93%
OCF growth 3YN/A
OCF growth 5YN/A

POXEL SA / POXEL.PA FAQ

What is the ChartMill fundamental rating of POXEL SA (POXEL.PA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to POXEL.PA.


What is the valuation status for POXEL stock?

ChartMill assigns a valuation rating of 2 / 10 to POXEL SA (POXEL.PA). This can be considered as Overvalued.


What is the profitability of POXEL stock?

POXEL SA (POXEL.PA) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for POXEL stock?

The Earnings per Share (EPS) of POXEL SA (POXEL.PA) is expected to decline by -10.48% in the next year.